Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo. [electronic resource]
- European journal of medicinal chemistry Mar 2019
- 293-308 p. digital
Publication Type: Journal Article
1768-3254
10.1016/j.ejmech.2019.01.004 doi
Animals Antineoplastic Agents--chemical synthesis Apoptosis Calcium--metabolism Cell Cycle Checkpoints--drug effects Cell Line, Tumor Drug Design Drug Screening Assays, Antitumor Heterografts Humans Quinoxalines--chemical synthesis Reactive Oxygen Species